AQP4 and amyloidosis: In fact, Zeppenfeld et al. (2017) also found an increase in global AQP4 immunoreactivity in the frontal cortex with increasing amyloid burden, but observed decreasing perivascular AQP4 immunoreactivity with both amyloid burden and Braak stage.